181 related articles for article (PubMed ID: 26184685)
1. Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies?
Frishman WH
Am J Med; 2015 Nov; 128(11):1160-1. PubMed ID: 26184685
[No Abstract] [Full Text] [Related]
2. [The IMPROVE-IT trial].
Menozzi A; Lina D; Urbinati S; Greco C
G Ital Cardiol (Rome); 2015 Dec; 16(12):667-71. PubMed ID: 26667942
[No Abstract] [Full Text] [Related]
3. [Letter].
Poli A
G Ital Cardiol (Rome); 2015 Dec; 16(12):739-40. PubMed ID: 26667952
[No Abstract] [Full Text] [Related]
4. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.
Virani SS; Akeroyd JM; Nambi V; Maddox TM; Gillette MA; Michael Ho P; Rumsfeld J; Petersen LA; Ballantyne CM
Am J Med; 2015 Nov; 128(11):1253-6. PubMed ID: 26071828
[TBL] [Abstract][Full Text] [Related]
5. [The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints].
Mascitelli L; Goldstein MR
G Ital Cardiol (Rome); 2015 Dec; 16(12):739. PubMed ID: 26667950
[No Abstract] [Full Text] [Related]
6. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
7. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
[TBL] [Abstract][Full Text] [Related]
8. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Singh JS; Struthers AD; Lang CC
N Engl J Med; 2015 Oct; 373(15):1476. PubMed ID: 26444741
[No Abstract] [Full Text] [Related]
9. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Richard T; Lelubre C; Vanhaeverbeek M
N Engl J Med; 2015 Oct; 373(15):1475-6. PubMed ID: 26444740
[No Abstract] [Full Text] [Related]
10. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Nunes JP
N Engl J Med; 2015 Oct; 373(15):1475. PubMed ID: 26444739
[No Abstract] [Full Text] [Related]
11. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Patti G; Cavallari I
N Engl J Med; 2015 Oct; 373(15):1474-5. PubMed ID: 26444738
[No Abstract] [Full Text] [Related]
12. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Egom EE
N Engl J Med; 2015 Oct; 373(15):1474. PubMed ID: 26444737
[No Abstract] [Full Text] [Related]
13. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Couture P; Durand M; Laskine M
N Engl J Med; 2015 Oct; 373(15):1473-4. PubMed ID: 26444736
[No Abstract] [Full Text] [Related]
14. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Silbernagel G; Baumgartner I; März W
N Engl J Med; 2015 Oct; 373(15):1473. PubMed ID: 26444735
[No Abstract] [Full Text] [Related]
15. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Cannon CP; Blazing MA; Braunwald E
N Engl J Med; 2015 Oct; 373(15):1476-7. PubMed ID: 26444734
[No Abstract] [Full Text] [Related]
16. [Role of ezetimibe in secondary cardiovascular prevention finally determined?].
Lanzi D; Fumeaux T
Rev Med Suisse; 2015 Nov; 11(496):2257. PubMed ID: 26742360
[No Abstract] [Full Text] [Related]
17. Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base.
Jialal I; Abate N
Metab Syndr Relat Disord; 2015 Oct; 13(8):327-8. PubMed ID: 26177147
[No Abstract] [Full Text] [Related]
18. Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
Li L; Zhang M; Su F; Li Y; Shen Y; Shen J; Zhang D
Lipids Health Dis; 2015 Feb; 14():10. PubMed ID: 25879728
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome.
Toth PP
Evid Based Med; 2015 Oct; 20(5):176. PubMed ID: 26261287
[No Abstract] [Full Text] [Related]
20. Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT Study.
Correia LC
Arq Bras Cardiol; 2016 Mar; 106(3):247-9. PubMed ID: 27027368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
